Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: Psychosom Med. 2014 Apr;76(3):215–220. doi: 10.1097/PSY.0000000000000050

Table 3. Diagnostic Evaluation of Patients with and without Schizophrenia.

Test No Schizophrenia
N (%)
Schizophrenia
N (%)
Test Use among Patients with Schizophrenia
Unadjusted2
OR1 (95% CI)
Adjusted3
OR (95% CI)
All Stages:
 Bronchoscopy 47,895 (50.2) 631 (48.4) 0.93 (0.84-1.04) 0.88 (0.79-0.98)
 Fine Needle Aspiration 39,677 (41.6) 542 (41.6) 1.00 (0.90-1.12) 1.01 (0.90-1.13)
 Positron Emission Test 11,428 (12.0) 111 (8.5) 0.68 (0.56-0.83) 0.68 (0.56-0.83)
 Chest Computed Tomography 80,640 (84.5) 1,069 (82.0) 0.84 (0.73-0.96) 0.84 (0.73-0.98)
 Mediastinoscopy 7,658 (8.0) 77 (5.9) 0.72 (0.57-0.91) 0.75 (0.59-0.95)
Stage II-IV:
 Brain Magnetic Resonance Imaging 144 (0.2) ≤11 (0.2) 1.08 (0.27-4.36) 1.00 (0.25-4.06)
If no PET:
 Abdominal Computed Tomography 32,054 (38.2) 373 (31.3) 0.74 (0.65-0.83) 0.78 (0.69-0.88)
 Bone Scan (stages III-IV) 28,625 (49.1) 316 (41.2) 0.73 (0.63-0.84) 0.74 (0.64-0.86)
1

OR = odds ratio

2

Logistic regression model, unadjusted

3

Logistic regression model, adjusted for age, gender, marital status, race/ethnicity, income, histology, comorbidities, and stage